Market Insight

Markets rarely move at random. InvestorPlace’s leading analysts break down macro trends, sector dynamics, and recurring market patterns to help investors understand what is changing, what matters most, and where opportunities may emerge.

Confidence in Consumer Discretionary is Key

By John Jagerson and Wade Hansen
One of our favorite ways to gauge whether we are in an expansion phase or a contraction phase is to compare consumer discretionary and consumer staples.

Rumors of a Sprint Corp/T-Mobile Merger Are Heating Up Again

By James Brumley, InvestorPlace Feature Writer
S stock has jumped on a return of rumors that Sprint is teaming up with T-Mobile. Whatever's in the cards, there are certainly riskier trades.

Congressional Hearings Likely Harden the Battle Lines Over Facebook, Inc. Stock

By Vince Martin, InvestorPlace Contributor
FB stock has plunged amid privacy and regulatory concerns, but seemingly better news has helped the stock this week. Still, Facebook and Zuckerberg have a lot more work to do to truly calm investor nerves.

Microsoft Corporation Goes All-In on the Internet of Things

By Tom Taulli, InvestorPlace Contributor
Microsoft stock has had a great run during the past few years. A big part has been a clear-cut strategic focus. Microsoft continues to gain momentum, especially with its cloud business. And the company's recent move on the IoT category will provide enormous opportunity.

3 Reasons Why Weed Inc Stock Could Surprise Investors

By Josh Enomoto, InvestorPlace Contributor
Weed stock has suffered catastrophic losses this year, but overlooked fundamentals could produce a surprise comeback.

Why Bitcoin Still Doesn’t Solve Any Problems

By Vince Martin, InvestorPlace Contributor
We're still in a bitcoin bubble, after all, Bitcoin is fixing problems we don't have ... and it is doing so poorly.

A Big Bet on Gene Therapy Is Just What Novartis AG (ADR) Stock Needs

By Chris Lau, InvestorPlace Contributor
Novartis put its excess cash to good use by broadening its business into the gene therapy market. Competition could prove tough for NVS stock, but Novartis is ready for the challenge ahead.

‘Fortnite’ Is Killing Take-Two Interactive Software, Inc Stock, But This Dip Is an Opportunity

By Luke Lango, InvestorPlace Senior Investment Analyst
TTWO stock has lost nearly a quarter of its value over the past two months due to 'Fortnite' risks, but the long-term fundamentals supporting Take-Two remain strong.

7 High-Risk Stocks That Could Double or Triple

By Anthony Mirhaydari, InvestorPlace Market Strategist
The recent market dips have produced some very undervalued names. These high-risk stocks show signs of rebound -- and significant gains for investors.

3 Stocks That Could Explode Higher This Earnings Season

By Luke Lango, InvestorPlace Senior Investment Analyst
Earnings season could be the thing that saves this struggling market, but earnings could be an especially big winner for these three recently troubled stocks.

After Its Beating, Funko Inc Stock Is Almost Too Cheap to Ignore

By Tom Taulli, InvestorPlace Contributor
Funko’s debut as a public company has been horrific. Yet the company has some positives. If anything, there could be a value opportunity here.

Trouble with Bots Is Just One Reason Twitter Inc Stock No Safe Bet

By Dana Blankenhorn, InvestorPlace Contributor
Twitter is making progress against bots, but the problems people cause one another are proving more difficult to overcome.

For Brave Investors, Wells Fargo & Co Stock Is a Buy for the Long Haul

By James Brumley, InvestorPlace Feature Writer
The headlines for WFC look grim, but if you can look past all the noise, Wells Fargo stock is a compelling bet right now.

Will Mattel, Inc. CEO Put the Toymaker’s Stock Back ‘In Play?’

By Jonathan Berr, InvestorPlace Contributor
While Mattel is making some significant changes to its business, the best option for MAT stock is still if Hasbro buys it out.

VeriFone Systems Inc: Take Your Pay on the Merger News

By Ian Bezek, InvestorPlace Contributor
VeriFone Systems stock has been in troubled waters for some time. A private equity firm has announced a deal to buy Verifone. What to do with PAY stock after the buyout offer? Here's why you should take some chips off the table.

4 Biotech Stocks With Leaky Pipelines

By Regina Borsellino
A strong pipeline can make or break biotech stocks, ensuring strong profits for years to come. These four biotech companies don't make the cut.

Under $10, It May Be Time to Buy Advanced Micro Devices, Inc. Stock

By Luke Lango, InvestorPlace Senior Investment Analyst
Near-term risks for Advanced Micro Devices have plunged AMD stock below $10, a level that looks like a good entry opportunity for long-term investors.

All Aboard! CSX Corporation Stock May Have 30% Upside

By Bret Kenwell, InvestorPlace Contributor
CSX Corporation has been surprisingly strong amid the trade-war worries pummeling the stock market. Should we stick with CSX stock and its big earnings growth?

3 Reasons to Be Bullish on Merck & Co., Inc. Stock

By Tom Taulli, InvestorPlace Contributor
Merck has had a tough year. But this does look like an opportunity for investors. MRK has a robust pipeline and Keytruda should continue to propel growth.
Load More Articles